News | July 23, 2008

New Contrast Delivery System Aims to Improve Efficiency

July 24, 2008 – Covidien recently launched the Optistar Elite contrast delivery system, designed to inject contrast media-related drugs into a patient’s vascular system to aid in obtaining diagnostic images when used with magnetic resonance (MR) imaging equipment.

The product recently received FDA approval and already carries a CE Mark.

The Optistar Elite aims to provide improved performance and ease of use, compared with the previous Optistar LE model.

Among the features on the Optistar Elite injector is patency check, which aids in preventing extravasation, assists in reducing the potential of certain medical errors and helps enhance clinical and work flow efficiency. Aimed at improving patient comfort, care and safety, the patency
check feature enables healthcare providers to confirm an unobstructed, or patent, fluid pathway to the patient prior to injection of contrast media-related drugs. A visual alert on the injector powerhead and on the control console also warns clinicians when the programmed pressure limit engages due to a blockage during the patency check.

The Optistar Elite, combined with the use of Covidien’s Ultraject prefilled syringes for contrast media-related drugs, can help decrease the risk of certain medication errors that may be caused by manually filling syringes. Designing the Optistar Elite to be compatible with the Ultraject prefilled syringes also eliminates syringe preparation and labeling steps, which helps meet certain regulatory requirements of the Joint Commission.

In addition, the powerhead buttons on the Optistar Elite injector are color-coordinated with the Ultraject prefilled syringes to help avoid medication errors resulting from the use of the wrong syringes and to help ensure proper procedural set up, while a status line banner guides technologists through each step of the set up process.

For more information: www.covidien.com

Related Content

ACR Offers Revised Contrast Media in Imaging Manual
News | Contrast Media| July 17, 2017
The American College of Radiology (ACR) recently revised its authoritative guide for the safe and effective use of...
Osprey Avert
News | Cath Lab| May 13, 2016
May 13, 2016 — In the largest study of its kind, a new device has been found to significantly reduce the volume of ra
GlobalData, contrast media injectors market,
News | Contrast Media Injectors| May 03, 2016
The global market for contrast media injectors is set to increase from $830 million in 2015 to almost $1.8 billion by...
Galt Medical, Health Line International Corp., Nexus CT Midline Catheter with MST Insertion Kit

Image courtesy of Galt Medical

Technology | Contrast Media Injectors| October 01, 2015
Galt Medical has partnered with Health Line International Corp. and launched the Nexus CT Midline Catheter with MST...
Technology | March 06, 2015
Bracco Imaging, through its business unit Bracco Injeneering SA, announced the availability of its EmpowerCTA+, an...
Contrast media injectors. angiography contrast injectors

The Bayer Arterion contrast injector.

Feature | Contrast Media Injectors| February 10, 2015 | Raissa Rocha and Dave Fornell
There have been several recent advances with contrast media injector technology, including cutting costs by reducing...
Technology | December 23, 2014
Bayer unveiled version 2.5 of its Radimetrics Enterprise Platform at the 2014 Radiological Society of North America (...
Technology | November 24, 2014
Bracco Diagnostics Inc. announced the availability of its Isovue (iopamidol injection) Imaging Bulk Package (IBP), a...
Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray
Feature | March 11, 2014
Guerbet announced a worldwide launch of FlowSens, a ...
Overlay Init